NewsStocks AbbVie Cuts Its Guidance on ImmunoGen Deal by admin 12/02/2024 12/02/2024 Key Takeaways AbbVie reduced its current quarter outlook related to costs from its acquisition of … 0 FacebookTwitterPinterestEmail
